China Pharma Holdings to launch dry eye disease therapeutic device in Q1, 2025

China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsi...

August 19, 2024 | Monday | News
Merck buys investigational B-cell depletion therapy from Chinese startup Curon Biopharma for $700 M

Merck, known as MSD outside of the United States and Canada, and Curon Biopharmaceutical, a China-based biotechnology st...

August 9, 2024 | Friday | News
Hong Kong develops smartphone stethoscope to support valvular heart disease detection

An interdisciplinary team from the Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKUMed) has developed...

August 5, 2024 | Monday | News
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market

Apexelsin, a generic drug from China been approved by the European Commission. Apexelsin is a generic dru...

July 31, 2024 | Wednesday | News
Porton Advanced and Geneseed Biotech focus on advancing circRNA innovative therapeutics in China

Porton Advanced Solutions,  a subsidiary of the globally recognised contract development and manufacturing org...

July 31, 2024 | Wednesday | News
Hong Kong government to develop rare disease centre

Professor Chung-mau Lo, Secretary for Health, has said that Hong Kong is developing a rare disease centre in collaborati...

July 30, 2024 | Tuesday | News
Hong Kong researchers suggest novel treatment approaches for glaucoma

Dr Samantha SHAN, Research Assistant Professor of the School of Optometry of The Hong Kong Polytechnic University (PolyU...

July 27, 2024 | Saturday | News
China's BeiGene opens new clinical R&D and biologics manufacturing facility in US

BeiGene, a China-based oncology company, has announced the opening of its flagship US facility in Hopewell, New Jersey, ...

July 24, 2024 | Wednesday | News
China-based startup Triastek to advance 3D printed oral RNA therapeutics in $1.2 B deal with BioNTech

Triastek Inc., a global leader in 3D printing pharmaceuticals, has entered into a research collaboration and platform te...

July 23, 2024 | Tuesday | News
China-Swiss collaboration to push forward ethical use of AI technology in healthcare

QingSong Health, a leading health technology platform based in China, has announced a strategic partnership with Globeth...

July 22, 2024 | Monday | News
China-based startup Rona Therapeutics raises $35 M to advance metabolic siRNA pipeline

China-based startup Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and de...

July 19, 2024 | Friday | News
Merck expands production capabilities for cell culture media with €6.6 M investment at Nantong site

Merck has announced the start of commercial production of its first GMP (Good Manufacturing Practices) compliant manufac...

July 16, 2024 | Tuesday | News
Sanyou Bio and BioGeometry join forces to create next-generation antibody drug discovery platform

BioGeometry and Sanyou Bio have jointly announced the signing of a strategic partnership agreement. China-based startup ...

July 15, 2024 | Monday | News
Hong Kong approves Eisai's Leqembi for treatment of Alzheimer’s Disease

Eisai Co. and Biogen Inc. have announced that the Department of Health in Hong Kong has approved humanised anti-soluble ...

July 11, 2024 | Thursday | News
Hong Kong identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders

The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among ...

July 12, 2024 | Friday | News
Ascentage Pharma receives commercialisation approval for oncology drug in Macau China

Ascentage Pharma has announced that its novel BCR-ABL1 tyrosine kinase inhibitor (TKI), olverembatinib, has been ap...

July 8, 2024 | Monday | News
China-based HiRO acquires CRO DeltaMed Solutions to expand cross-border operations in US

China-based Harvest Integrated Research Organization (HiRO), a full-service, boutique global contract research organisat...

July 3, 2024 | Wednesday | News
Chinese startup Hasten Biopharma buys 14 products from Korean firm Celltrion

China-based startup Hasten Biopharmaceutical has successfully acquired the asset rights of 14 branded products across Pa...

July 2, 2024 | Tuesday | News